ArticleThe European respiratory journal2025
Attenuated benefit to vasodilators in patients with pulmonary arterial hypertension and high probability of heart failure with preserved ejection fraction.
Yogesh N V Reddy, Robert P Frantz, Hilary M Dubrock, Anna R Hemnes, Evelyn M Horn, Teresa De Marco, Charles Burger, Stephen C Mathai, Steven M Kawut, Barry A Borlaug and 1 more
Abstract readLetter
In one paragraphArticle in The European respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Yogesh N V ReddyThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA reddy.yogesh@mayo.edu.
Hilary M DubrockThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Anna R HemnesDivision of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Evelyn M HornPerkin Heart Failure Center, Division of Cardiology, Weill Cornell Medicine, New York, NY, USA.
Teresa De MarcoDivision of Cardiology, University of California, San Francisco, CA, USA.
Charles BurgerDivision of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, FL, USA.
Barry A BorlaugThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
PHAR investigators
Funding
Pulmonary Hypertension in Left Heart DiseaseR01HL162828 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug, Margaret M Redfield · 2023 to 2026
$3.1MHL-Inorganic Nitrite to Enhance Benefits from Exercise Training in Heart Failure with preserved Ejection FractionR01HL128526 · NHLBI · MAYO CLINIC ROCHESTER · PI BORLAUG, BARRY A. · 2016 to 2019
$2.4MMayo Clinic HeartShare Clinical CenterU01HL160226 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug, Margaret M Redfield · 2021 to 2026
$1.8MPeripheral Limitations in Pulmonary Hypertension and Effects of Muscle TrainingK23HL164901 · NHLBI · MAYO CLINIC ROCHESTER · PI Yogesh Nellore Vilambi Reddy · 2023 to 2026
$671kNHLBI NIH HHS K23 HL164901NHLBI NIH HHS R01 HL128526NHLBI NIH HHS R01 HL162828NHLBI NIH HHS U01 HL160226
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40639872
PMCPMC12883150
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390